HEADER HYDROLASE/HYDROLASE INHIBITOR 20-JUN-05 2A1D TITLE STAPHYLOCOAGULASE BOUND TO BOVINE THROMBIN CAVEAT 2A1D 0G6 B 500 HAS WRONG CHIRALITY AT ATOM C2 NAG B 700 HAS WRONG CAVEAT 2 2A1D CHIRALITY AT ATOM C1 0G6 F 600 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 2A1D C2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: THROMBIN LIGHT CHAIN; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THROMBIN; COMPND 9 CHAIN: B, F; COMPND 10 FRAGMENT: THROMBIN HEAVY CHAIN; COMPND 11 SYNONYM: COAGULATION FACTOR II; COMPND 12 EC: 3.4.21.5; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: STAPHYLOCOAGULASE; COMPND 15 CHAIN: D, H; COMPND 16 FRAGMENT: ACTIVE FRAGMENT 1-329; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 7 ORGANISM_COMMON: CATTLE; SOURCE 8 ORGANISM_TAXID: 9913; SOURCE 9 MOL_ID: 3; SOURCE 10 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 11 ORGANISM_TAXID: 1280; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTHROMBIN ACTIVATOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.FRIEDRICH,P.PANIZZI,S.KAWABATA,W.BODE,P.E.BOCK,P.FUENTES-PRIOR REVDAT 7 03-APR-24 2A1D 1 REMARK REVDAT 6 20-MAR-24 2A1D 1 COMPND SOURCE REMARK HETSYN REVDAT 5 29-JUL-20 2A1D 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HET HETNAM LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 13-JUL-11 2A1D 1 VERSN REVDAT 3 24-FEB-09 2A1D 1 VERSN REVDAT 2 24-JAN-06 2A1D 1 JRNL REVDAT 1 27-SEP-05 2A1D 0 JRNL AUTH R.FRIEDRICH,P.PANIZZI,S.KAWABATA,W.BODE,P.E.BOCK, JRNL AUTH 2 P.FUENTES-PRIOR JRNL TITL STRUCTURAL BASIS FOR REDUCED STAPHYLOCOAGULASE-MEDIATED JRNL TITL 2 BOVINE PROTHROMBIN ACTIVATION JRNL REF J.BIOL.CHEM. V. 281 1188 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16230338 JRNL DOI 10.1074/JBC.M507957200 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.7 REMARK 3 NUMBER OF REFLECTIONS : 21210 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.306 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 420 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 36.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 28 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.075 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9558 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.36000 REMARK 3 B22 (A**2) : -1.04000 REMARK 3 B33 (A**2) : -0.32000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 9.55000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.48 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.57 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.72 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A1D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-JUN-05. REMARK 100 THE DEPOSITION ID IS D_1000033369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-97 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 138556 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.400 REMARK 200 RESOLUTION RANGE LOW (A) : 55.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: HUMAN THROMBIN-STAPHYLOCOAGULASE COMPLEX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M IMIDAZOLE, 0.2M AMMONIUM FORMATE, REMARK 280 12% POLYETHYLENE GLYCOL 4000, PH 6.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 91.89000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.27000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 91.89000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 51.27000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU D 282 REMARK 465 SER D 283 REMARK 465 GLU D 284 REMARK 465 THR D 285 REMARK 465 LYS D 286 REMARK 465 SER D 287 REMARK 465 PRO D 288 REMARK 465 VAL D 289 REMARK 465 VAL D 290 REMARK 465 LYS D 291 REMARK 465 GLU D 292 REMARK 465 GLU D 293 REMARK 465 ASN D 294 REMARK 465 LYS D 295 REMARK 465 VAL D 296 REMARK 465 GLU D 297 REMARK 465 ASP D 298 REMARK 465 PRO D 299 REMARK 465 GLN D 300 REMARK 465 SER D 301 REMARK 465 PRO D 302 REMARK 465 LYS D 303 REMARK 465 PHE D 304 REMARK 465 ASP D 305 REMARK 465 ASN D 306 REMARK 465 GLN D 307 REMARK 465 GLN D 308 REMARK 465 GLU D 309 REMARK 465 VAL D 310 REMARK 465 LYS D 311 REMARK 465 THR D 312 REMARK 465 THR D 313 REMARK 465 ALA D 314 REMARK 465 GLY D 315 REMARK 465 LYS D 316 REMARK 465 ALA D 317 REMARK 465 GLU D 318 REMARK 465 GLU D 319 REMARK 465 THR D 320 REMARK 465 THR D 321 REMARK 465 GLN D 322 REMARK 465 PRO D 323 REMARK 465 VAL D 324 REMARK 465 ALA D 325 REMARK 465 GLN D 326 REMARK 465 PRO D 327 REMARK 465 LEU D 328 REMARK 465 GLU H 282 REMARK 465 SER H 283 REMARK 465 GLU H 284 REMARK 465 THR H 285 REMARK 465 LYS H 286 REMARK 465 SER H 287 REMARK 465 PRO H 288 REMARK 465 VAL H 289 REMARK 465 VAL H 290 REMARK 465 LYS H 291 REMARK 465 GLU H 292 REMARK 465 GLU H 293 REMARK 465 ASN H 294 REMARK 465 LYS H 295 REMARK 465 VAL H 296 REMARK 465 GLU H 297 REMARK 465 ASP H 298 REMARK 465 PRO H 299 REMARK 465 GLN H 300 REMARK 465 SER H 301 REMARK 465 PRO H 302 REMARK 465 LYS H 303 REMARK 465 PHE H 304 REMARK 465 ASP H 305 REMARK 465 ASN H 306 REMARK 465 GLN H 307 REMARK 465 GLN H 308 REMARK 465 GLU H 309 REMARK 465 VAL H 310 REMARK 465 LYS H 311 REMARK 465 THR H 312 REMARK 465 THR H 313 REMARK 465 ALA H 314 REMARK 465 GLY H 315 REMARK 465 LYS H 316 REMARK 465 ALA H 317 REMARK 465 GLU H 318 REMARK 465 GLU H 319 REMARK 465 THR H 320 REMARK 465 THR H 321 REMARK 465 GLN H 322 REMARK 465 PRO H 323 REMARK 465 VAL H 324 REMARK 465 ALA H 325 REMARK 465 GLN H 326 REMARK 465 PRO H 327 REMARK 465 LEU H 328 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 THR B 149 CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER F 195 O2 0G6 F 600 1.57 REMARK 500 OG SER B 195 O2 0G6 B 500 1.63 REMARK 500 OG SER F 195 C3 0G6 F 600 1.77 REMARK 500 OG SER B 195 C3 0G6 B 500 1.84 REMARK 500 CE1 HIS F 57 C3 0G6 F 600 1.91 REMARK 500 CE1 HIS B 57 C3 0G6 B 500 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 60B C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 ARG D 116 NE - CZ - NH1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG D 116 NE - CZ - NH2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG D 262 CD - NE - CZ ANGL. DEV. = 10.8 DEGREES REMARK 500 ARG D 262 NE - CZ - NH1 ANGL. DEV. = -7.5 DEGREES REMARK 500 ARG D 262 NE - CZ - NH2 ANGL. DEV. = 7.3 DEGREES REMARK 500 PRO F 60B C - N - CA ANGL. DEV. = 9.9 DEGREES REMARK 500 ARG H 116 CD - NE - CZ ANGL. DEV. = 8.5 DEGREES REMARK 500 ARG H 116 NE - CZ - NH1 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG H 116 NE - CZ - NH2 ANGL. DEV. = 6.1 DEGREES REMARK 500 ARG H 262 CD - NE - CZ ANGL. DEV. = 10.1 DEGREES REMARK 500 ARG H 262 NE - CZ - NH1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG H 262 NE - CZ - NH2 ANGL. DEV. = -7.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 1J -38.58 -34.62 REMARK 500 CYS A 1 156.31 -28.80 REMARK 500 PRO A 5 -15.70 -48.31 REMARK 500 PHE A 7 -74.90 -142.08 REMARK 500 GLU A 8 -80.14 -50.38 REMARK 500 LYS A 9 52.71 -61.68 REMARK 500 LYS A 10 13.13 -178.67 REMARK 500 GLN A 14A -24.50 -37.61 REMARK 500 THR A 14B 52.69 -143.09 REMARK 500 GLN B 20 137.58 -175.66 REMARK 500 VAL B 24 116.90 -18.44 REMARK 500 ALA B 44 -168.73 -164.60 REMARK 500 SER B 48 -138.39 -162.87 REMARK 500 ARG B 50 -5.14 -154.70 REMARK 500 ALA B 56 -39.90 -35.67 REMARK 500 TYR B 60A 76.51 -171.77 REMARK 500 PRO B 60B -35.23 -37.46 REMARK 500 ASN B 60G 83.02 -174.30 REMARK 500 HIS B 71 -54.17 -178.78 REMARK 500 THR B 74 -98.91 -68.58 REMARK 500 GLU B 77 73.33 -114.63 REMARK 500 PRO B 92 -72.12 -56.13 REMARK 500 ARG B 93 31.03 -63.11 REMARK 500 ASN B 98 19.75 -145.85 REMARK 500 ASP B 116 6.26 -67.72 REMARK 500 PRO B 124 150.26 -38.46 REMARK 500 THR B 149 56.62 -68.58 REMARK 500 THR B 149A -175.65 -58.64 REMARK 500 ALA B 149D -69.87 -105.99 REMARK 500 GLU B 149E 81.57 -31.05 REMARK 500 VAL B 150 31.79 -143.10 REMARK 500 ARG B 165 -55.09 -26.03 REMARK 500 SER B 171 17.94 -64.90 REMARK 500 ASP B 178 -9.21 -56.87 REMARK 500 ASN B 179 31.93 -95.75 REMARK 500 MET B 180 148.09 -172.34 REMARK 500 LYS B 186D -177.63 -60.69 REMARK 500 ASP B 189 163.46 172.97 REMARK 500 CYS B 191 -153.62 -135.98 REMARK 500 SER B 195 -105.26 -13.94 REMARK 500 ASN B 204B 30.39 178.25 REMARK 500 ASN B 205 52.81 23.82 REMARK 500 ARG B 221A -176.21 -64.61 REMARK 500 LYS B 240 -30.36 -39.40 REMARK 500 ASP B 243 39.75 -76.00 REMARK 500 LEU B 245 107.17 -55.56 REMARK 500 LYS D 4 -110.74 -105.72 REMARK 500 GLU D 9 11.21 -146.44 REMARK 500 ARG D 11 31.44 -94.35 REMARK 500 ASN D 15 72.53 -67.61 REMARK 500 REMARK 500 THIS ENTRY HAS 147 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR IS COVALENTLY CONNECTED TO ACTIVE_SITE REMARK 600 RESIDUES: REMARK 600 1) VIA A HEMIKETAL GROUP TO OG SER 195 IN CHAINS B AND F, REMARK 600 2) VIA A METHYLENE GROUP TO NE2 HIS 57 IN CHAINS B AND F. REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0G6 B 500 REMARK 630 0G6 F 600 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: DPN PRO AR7 0QE REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NU7 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE BOUND TO HUMAN THROMBIN REMARK 900 RELATED ID: 1NU9 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE BOUND TO HUMAN PRETHROMBIN-2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS DIVERGENCE OF GLY FROM THE REPORTED SEQUENCE, REMARK 999 PERHAPS ADDING THAT THIS VARIATION IS IRRELEVANT FOR REMARK 999 (PRO)THROMBIN BINDING, WHICH IS AN IMPORTANT POINT REMARK 999 OF THIS ENTRY. DBREF 2A1D A 1M 15 UNP P00735 THRB_BOVIN 326 366 DBREF 2A1D E 1M 15 UNP P00735 THRB_BOVIN 326 366 DBREF 2A1D B 16 247 UNP P00735 THRB_BOVIN 367 625 DBREF 2A1D F 16 247 UNP P00735 THRB_BOVIN 367 625 DBREF 2A1D D 1 328 UNP P17855 STC2_STAAU 27 355 DBREF 2A1D H 1 328 UNP P17855 STC2_STAAU 27 355 SEQADV 2A1D MET D 0 UNP P17855 INITIATING METHIONINE SEQADV 2A1D D UNP P17855 GLY 126 SEE REMARK 999 SEQADV 2A1D MET H 0 UNP P17855 INITIATING METHIONINE SEQADV 2A1D H UNP P17855 GLY 126 SEE REMARK 999 SEQRES 1 A 41 PHE PHE ASN GLU LYS THR PHE GLY ALA GLY GLU ALA ASP SEQRES 2 A 41 CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS GLN VAL GLN SEQRES 3 A 41 ASP GLN THR GLU LYS GLU LEU PHE GLU SER TYR ILE GLU SEQRES 4 A 41 GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY GLN ASP ALA GLU VAL GLY LEU SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR VAL ASP ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG LYS VAL GLU LYS ILE SEQRES 7 B 259 SER MET LEU ASP LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP LYS GLU ASN LEU ASP ARG ASP ILE ALA LEU LEU LYS SEQRES 9 B 259 LEU LYS ARG PRO ILE GLU LEU SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP LYS GLN THR ALA ALA LYS LEU LEU SEQRES 11 B 259 HIS ALA GLY PHE LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 ARG ARG GLU THR TRP THR THR SER VAL ALA GLU VAL GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO LEU VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ALA SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO GLY GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO TYR ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP ARG LEU GLY SER SEQRES 1 D 329 MET ILE VAL THR LYS ASP TYR SER LYS GLU SER ARG VAL SEQRES 2 D 329 ASN GLU ASN SER LYS TYR GLY THR LEU ILE SER ASP TRP SEQRES 3 D 329 TYR LEU LYS GLY ARG LEU THR SER LEU GLU SER GLN PHE SEQRES 4 D 329 ILE ASN ALA LEU ASP ILE LEU GLU THR TYR HIS TYR GLY SEQRES 5 D 329 GLU LYS GLU TYR LYS ASP ALA LYS ASP LYS LEU MET THR SEQRES 6 D 329 ARG ILE LEU GLY GLU ASP GLN TYR LEU LEU GLU ARG LYS SEQRES 7 D 329 LYS VAL GLN TYR GLU GLU TYR LYS LYS LEU TYR GLN LYS SEQRES 8 D 329 TYR LYS GLU GLU ASN PRO THR SER LYS LEU LYS LEU LYS SEQRES 9 D 329 THR PHE ASP GLN TYR THR ILE GLU ASP LEU THR MET ARG SEQRES 10 D 329 GLU TYR ASN GLU LEU THR GLU SER LEU LYS SER ALA VAL SEQRES 11 D 329 LYS ASP PHE GLU LYS ASP VAL GLU LYS ILE GLU ASN GLN SEQRES 12 D 329 HIS HIS ASP LEU LYS PRO PHE THR ASP GLU MET GLU GLU SEQRES 13 D 329 LYS ALA THR SER ARG VAL ASP ASP LEU ALA ASN LYS ALA SEQRES 14 D 329 TYR SER VAL TYR PHE ALA PHE VAL ARG ASP THR GLN HIS SEQRES 15 D 329 LYS THR GLU ALA LEU GLU LEU LYS ALA LYS VAL ASP LEU SEQRES 16 D 329 VAL LEU GLY ASP GLU ASP LYS PRO HIS ARG ILE SER ASN SEQRES 17 D 329 GLU ARG ILE GLU LYS GLU MET ILE LYS ASP LEU GLU SER SEQRES 18 D 329 ILE ILE GLU ASP PHE PHE ILE GLU THR GLY LEU ASN LYS SEQRES 19 D 329 PRO GLY ASN ILE THR SER TYR ASP SER SER LYS HIS HIS SEQRES 20 D 329 TYR LYS ASN HIS SER GLU GLY PHE GLU ALA LEU VAL LYS SEQRES 21 D 329 GLU THR ARG GLU ALA VAL ALA ASN ALA ASP GLU SER TRP SEQRES 22 D 329 LYS THR LYS THR VAL LYS LYS TYR GLY GLU SER GLU THR SEQRES 23 D 329 LYS SER PRO VAL VAL LYS GLU GLU ASN LYS VAL GLU ASP SEQRES 24 D 329 PRO GLN SER PRO LYS PHE ASP ASN GLN GLN GLU VAL LYS SEQRES 25 D 329 THR THR ALA GLY LYS ALA GLU GLU THR THR GLN PRO VAL SEQRES 26 D 329 ALA GLN PRO LEU SEQRES 1 E 41 PHE PHE ASN GLU LYS THR PHE GLY ALA GLY GLU ALA ASP SEQRES 2 E 41 CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS GLN VAL GLN SEQRES 3 E 41 ASP GLN THR GLU LYS GLU LEU PHE GLU SER TYR ILE GLU SEQRES 4 E 41 GLY ARG SEQRES 1 F 259 ILE VAL GLU GLY GLN ASP ALA GLU VAL GLY LEU SER PRO SEQRES 2 F 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 F 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 F 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 F 259 ASN PHE THR VAL ASP ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 F 259 HIS SER ARG THR ARG TYR GLU ARG LYS VAL GLU LYS ILE SEQRES 7 F 259 SER MET LEU ASP LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 F 259 TRP LYS GLU ASN LEU ASP ARG ASP ILE ALA LEU LEU LYS SEQRES 9 F 259 LEU LYS ARG PRO ILE GLU LEU SER ASP TYR ILE HIS PRO SEQRES 10 F 259 VAL CYS LEU PRO ASP LYS GLN THR ALA ALA LYS LEU LEU SEQRES 11 F 259 HIS ALA GLY PHE LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 F 259 ARG ARG GLU THR TRP THR THR SER VAL ALA GLU VAL GLN SEQRES 13 F 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO LEU VAL GLU SEQRES 14 F 259 ARG PRO VAL CYS LYS ALA SER THR ARG ILE ARG ILE THR SEQRES 15 F 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO GLY GLU GLY SEQRES 16 F 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 F 259 PHE VAL MET LYS SER PRO TYR ASN ASN ARG TRP TYR GLN SEQRES 18 F 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 F 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 F 259 LYS TRP ILE GLN LYS VAL ILE ASP ARG LEU GLY SER SEQRES 1 H 329 MET ILE VAL THR LYS ASP TYR SER LYS GLU SER ARG VAL SEQRES 2 H 329 ASN GLU ASN SER LYS TYR GLY THR LEU ILE SER ASP TRP SEQRES 3 H 329 TYR LEU LYS GLY ARG LEU THR SER LEU GLU SER GLN PHE SEQRES 4 H 329 ILE ASN ALA LEU ASP ILE LEU GLU THR TYR HIS TYR GLY SEQRES 5 H 329 GLU LYS GLU TYR LYS ASP ALA LYS ASP LYS LEU MET THR SEQRES 6 H 329 ARG ILE LEU GLY GLU ASP GLN TYR LEU LEU GLU ARG LYS SEQRES 7 H 329 LYS VAL GLN TYR GLU GLU TYR LYS LYS LEU TYR GLN LYS SEQRES 8 H 329 TYR LYS GLU GLU ASN PRO THR SER LYS LEU LYS LEU LYS SEQRES 9 H 329 THR PHE ASP GLN TYR THR ILE GLU ASP LEU THR MET ARG SEQRES 10 H 329 GLU TYR ASN GLU LEU THR GLU SER LEU LYS SER ALA VAL SEQRES 11 H 329 LYS ASP PHE GLU LYS ASP VAL GLU LYS ILE GLU ASN GLN SEQRES 12 H 329 HIS HIS ASP LEU LYS PRO PHE THR ASP GLU MET GLU GLU SEQRES 13 H 329 LYS ALA THR SER ARG VAL ASP ASP LEU ALA ASN LYS ALA SEQRES 14 H 329 TYR SER VAL TYR PHE ALA PHE VAL ARG ASP THR GLN HIS SEQRES 15 H 329 LYS THR GLU ALA LEU GLU LEU LYS ALA LYS VAL ASP LEU SEQRES 16 H 329 VAL LEU GLY ASP GLU ASP LYS PRO HIS ARG ILE SER ASN SEQRES 17 H 329 GLU ARG ILE GLU LYS GLU MET ILE LYS ASP LEU GLU SER SEQRES 18 H 329 ILE ILE GLU ASP PHE PHE ILE GLU THR GLY LEU ASN LYS SEQRES 19 H 329 PRO GLY ASN ILE THR SER TYR ASP SER SER LYS HIS HIS SEQRES 20 H 329 TYR LYS ASN HIS SER GLU GLY PHE GLU ALA LEU VAL LYS SEQRES 21 H 329 GLU THR ARG GLU ALA VAL ALA ASN ALA ASP GLU SER TRP SEQRES 22 H 329 LYS THR LYS THR VAL LYS LYS TYR GLY GLU SER GLU THR SEQRES 23 H 329 LYS SER PRO VAL VAL LYS GLU GLU ASN LYS VAL GLU ASP SEQRES 24 H 329 PRO GLN SER PRO LYS PHE ASP ASN GLN GLN GLU VAL LYS SEQRES 25 H 329 THR THR ALA GLY LYS ALA GLU GLU THR THR GLN PRO VAL SEQRES 26 H 329 ALA GLN PRO LEU MODRES 2A1D ASN B 60G ASN GLYCOSYLATION SITE HET 0G6 B 500 30 HET NAG B 700 14 HET NA B 901 1 HET 0G6 F 600 30 HET NA F 902 1 HETNAM 0G6 D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO) HETNAM 2 0G6 METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L- HETNAM 3 0G6 PROLINAMIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NA SODIUM ION HETSYN 0G6 PPACK HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 0G6 2(C21 H34 CL N6 O3 1+) FORMUL 8 NAG C8 H15 N O6 FORMUL 9 NA 2(NA 1+) HELIX 1 1 ASN A 1K GLY A 1F 1 6 HELIX 2 2 PHE A 7 GLN A 11 5 5 HELIX 3 3 GLU A 14C ILE A 14K 1 9 HELIX 4 4 ALA B 55 CYS B 58 5 4 HELIX 5 5 PRO B 60B ASP B 60E 5 4 HELIX 6 6 GLN B 127 LEU B 130 1 7 HELIX 7 7 GLU B 164 SER B 171 1 8 HELIX 8 8 VAL B 231 ASP B 243 1 13 HELIX 9 9 SER D 23 THR D 47 1 25 HELIX 10 10 TYR D 48 GLY D 51 5 4 HELIX 11 11 TYR D 55 GLU D 93 1 39 HELIX 12 12 THR D 114 GLN D 142 1 29 HELIX 13 13 HIS D 143 LYS D 147 5 5 HELIX 14 14 THR D 150 ARG D 177 1 28 HELIX 15 15 HIS D 181 GLY D 197 1 17 HELIX 16 16 ASN D 207 GLY D 230 1 24 HELIX 17 17 HIS D 250 ALA D 268 1 19 HELIX 18 18 SER D 271 LYS D 275 5 5 HELIX 19 19 ASN E 1K GLY E 1F 1 6 HELIX 20 20 PHE E 7 GLN E 11 5 5 HELIX 21 21 GLU E 14C ILE E 14K 1 9 HELIX 22 22 ALA F 55 CYS F 58 5 4 HELIX 23 23 PRO F 60B ASP F 60E 5 4 HELIX 24 24 GLN F 127 LEU F 130 1 7 HELIX 25 25 GLU F 164 SER F 171 1 8 HELIX 26 26 VAL F 231 ASP F 243 1 13 HELIX 27 27 SER H 23 THR H 47 1 25 HELIX 28 28 TYR H 48 GLY H 51 5 4 HELIX 29 29 TYR H 55 GLU H 93 1 39 HELIX 30 30 THR H 114 GLN H 142 1 29 HELIX 31 31 HIS H 143 LYS H 147 5 5 HELIX 32 32 THR H 150 ARG H 177 1 28 HELIX 33 33 HIS H 181 GLY H 197 1 17 HELIX 34 34 ASN H 207 GLY H 230 1 24 HELIX 35 35 HIS H 250 ALA H 268 1 19 HELIX 36 36 SER H 271 LYS H 275 5 5 SHEET 1 A 7 GLN B 30 ARG B 35 0 SHEET 2 A 7 GLU B 39 LEU B 46 -1 O GLU B 39 N ARG B 35 SHEET 3 A 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 4 A 7 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54 SHEET 5 A 7 LYS B 81 ILE B 90 -1 N ASP B 86 O LYS B 107 SHEET 6 A 7 LEU B 64 ILE B 68 -1 N ILE B 68 O LYS B 81 SHEET 7 A 7 GLN B 30 ARG B 35 -1 N PHE B 34 O LEU B 65 SHEET 1 B 2 LEU B 60 TYR B 60A 0 SHEET 2 B 2 LYS B 60F ASN B 60G-1 O LYS B 60F N TYR B 60A SHEET 1 C 6 GLN B 156 VAL B 158 0 SHEET 2 C 6 ARG B 137 GLY B 140 -1 N VAL B 138 O VAL B 158 SHEET 3 C 6 PRO B 198 SER B 203 -1 O VAL B 200 N ARG B 137 SHEET 4 C 6 ARG B 206 TRP B 215 -1 O TYR B 208 N MET B 201 SHEET 5 C 6 GLY B 226 HIS B 230 -1 O THR B 229 N ILE B 212 SHEET 6 C 6 MET B 180 ALA B 183 -1 N PHE B 181 O TYR B 228 SHEET 1 D 7 GLN F 30 ARG F 35 0 SHEET 2 D 7 GLU F 39 LEU F 46 -1 O GLU F 39 N ARG F 35 SHEET 3 D 7 TRP F 51 THR F 54 -1 O LEU F 53 N SER F 45 SHEET 4 D 7 ALA F 104 LEU F 108 -1 O ALA F 104 N THR F 54 SHEET 5 D 7 LYS F 81 ILE F 90 -1 N ASP F 86 O LYS F 107 SHEET 6 D 7 LEU F 64 ILE F 68 -1 N ILE F 68 O LYS F 81 SHEET 7 D 7 GLN F 30 ARG F 35 -1 N PHE F 34 O LEU F 65 SHEET 1 E 2 LEU F 60 TYR F 60A 0 SHEET 2 E 2 LYS F 60F ASN F 60G-1 O LYS F 60F N TYR F 60A SHEET 1 F 6 GLN F 156 VAL F 158 0 SHEET 2 F 6 ARG F 137 GLY F 140 -1 N VAL F 138 O VAL F 158 SHEET 3 F 6 PRO F 198 SER F 203 -1 O VAL F 200 N ARG F 137 SHEET 4 F 6 ARG F 206 TRP F 215 -1 O TYR F 208 N MET F 201 SHEET 5 F 6 GLY F 226 HIS F 230 -1 O THR F 229 N ILE F 212 SHEET 6 F 6 MET F 180 ALA F 183 -1 N PHE F 181 O TYR F 228 SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.03 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.02 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.02 SSBOND 5 CYS E 1 CYS F 122 1555 1555 2.02 SSBOND 6 CYS F 42 CYS F 58 1555 1555 2.03 SSBOND 7 CYS F 168 CYS F 182 1555 1555 2.03 SSBOND 8 CYS F 191 CYS F 220 1555 1555 2.03 LINK NE2 HIS B 57 C3 0G6 B 500 1555 1555 1.46 LINK ND2 ASN B 60G C1 NAG B 700 1555 1555 1.46 LINK OG SER B 195 C2 0G6 B 500 1555 1555 1.40 LINK NE2 HIS F 57 C3 0G6 F 600 1555 1555 1.46 LINK OG SER F 195 C2 0G6 F 600 1555 1555 1.40 CISPEP 1 SER B 36A PRO B 37 0 -0.23 CISPEP 2 SER F 36A PRO F 37 0 -0.24 CRYST1 183.780 102.540 134.040 90.00 129.14 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005441 0.000000 0.004428 0.00000 SCALE2 0.000000 0.009752 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009619 0.00000